Celltrion
068270.KS
#810
Rank
NZ$54.39 B
Marketcap
NZ$238.53
Share price
-2.13%
Change (1 day)
10.64%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Dividend history for Celltrion (068270.KS)

Celltrion (stock symbol: 068270.KS) made a total of 10 dividend payments.
The sum of all dividends (adjusted for stock splits) is : NZ$3.90
Dividend yield (TTM) : 0.39% See Celltrion dividend yield history

Dividend payments for Celltrion (068270.KS) from 2006 to 2025

Annual dividend payments

Year Dividend (stock split adjusted) Change
2025 NZ$0.93 9.20%
2024 NZ$0.86 50.00%
2023 NZ$0.57 33.33%
2022 NZ$0.43-48.00%
2021 NZ$0.82 3,764.42%
2012 NZ$0.02130-77.75%
2011 NZ$0.09570 33.33%
2010 NZ$0.07178 50.00%
2007 NZ$0.04785N/A
2006 NZ$0.04785N/A

List of all dividend payments

Date Dividend (stock split adjusted) Change
2025-12-29NZ$0.93 9.20%
2024-12-27NZ$0.86 50.00%
2023-12-27NZ$0.57 33.33%
2022-12-28NZ$0.43-48.00%
2021-12-29NZ$0.82 3,764.42%
2012-12-27NZ$0.02130-77.75%
2011-12-28NZ$0.09570 33.33%
2010-12-29NZ$0.07178 50.00%
2007-12-27NZ$0.04785N/A
2006-12-27NZ$0.04785N/A